SS
VIR icon

SBI Securities’s Vir Biotechnology VIR Stock Holding History

SBI Securities’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2K Sell
4,156
-2,298
-36% -$18.3K ﹤0.01% 1214
2025
Q4 		$38.9K Sell
6,454
-1,632
-20% -$9.72K ﹤0.01% 1180
2025
Q3 		$46.2K Sell
8,086
-153
-2% -$782 ﹤0.01% 1119
2025
Q2 		$41.5K Buy
8,239
+84
+1% +$450 ﹤0.01% 1121
2025
Q1 		$52.8K Sell
8,155
-67
-0.8% -$596 ﹤0.01% 956
2024
Q4 		$60.3K Buy
+8,222
New +$64.9K ﹤0.01% 917

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SBI Securities's VIR Position: Q1 2026 in Review

SBI Securities reduced its Vir Biotechnology (VIR) stake by 36% in Q1 2026, selling an estimated $18.3K and leaving 4,156 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

SBI Securities first reported a position in VIR in Q4 2024 and has held it in 6 quarters since. The position peaked at $60.3K in Q4 2024. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • SBI Securities held 4,156 shares of Vir Biotechnology worth $37.2K as of Q1 2026.
  • SBI Securities sold 2,298 Vir Biotechnology shares in Q1 2026, an estimated $18.3K.
  • Vir Biotechnology made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1214 holding.
  • SBI Securities first reported a position in Vir Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Vir Biotechnology position peaked at $60.3K in Q4 2024.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.